Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.73 |
| ▸ | KDM1A | O60341 | 9/20 | 0.71 |
| ▸ | MAOA | P21397 | 7/20 | 0.71 |
| ▸ | RCOR1 | Q9UKL0 | 3/20 | 0.71 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.71 |
| ▸ | MAOB | P27338 | 2/20 | 0.70 |
| ▸ | F2 | P00734 | 3/20 | 0.69 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.69 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.69 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.69 |
| ▸ | TACR1 | P25103 | 2/20 | 0.68 |
| ▸ | CTSL | P07711 | 1/20 | 0.67 |
| ▸ | CTSB | P07858 | 1/20 | 0.67 |
| ▸ | CTSS | P25774 | 1/20 | 0.67 |
| ▸ | CTSK | P43235 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4155113 | 0.91 | KDM1A (0.68) | HDAC8KDM1AMAOARCOR1KDM1B | |
| SCHEMBL18444606 | 0.91 | KDM1A (0.68) | HDAC8KDM1AMAOARCOR1KDM1B | |
| SCHEMBL7038484 | 0.91 | HDAC8 (0.78) | HDAC8KDM1AMAOARCOR1KDM1B | |
| SCHEMBL4154649 | 0.89 | HDAC8 (0.80) | HDAC8KDM1AMAOARCOR1KDM1B | |
| SCHEMBL13768439 | 0.89 | HDAC8 (0.63) | HDAC8KDM1AMAOARCOR1KDM1B | |
| SCHEMBL4154299 | 0.88 | TACR1 (0.67) | HDAC8KDM1AMAOARCOR1KDM1B | |
| SCHEMBL13768441 | 0.88 | KDM1A (0.61) | HDAC8KDM1AMAOARCOR1KDM1B | |
| SCHEMBL4156354 | 0.88 | HDAC8 (0.60) | HDAC8KDM1AMAOARCOR1KDM1B | |
| SCHEMBL7970027 | 0.88 | TACR1 (0.70) | HDAC8KDM1AMAOARCOR1KDM1B | |
| SCHEMBL13768273 | 0.88 | SIRT5 (0.62) | HDAC8KDM1AMAOARCOR1KDM1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009080631-A2 | CHEMO-ENZYMATIC SYNTHESIS OF A C-TERMINAL ARYL AMIDE OF AN AMINO ACID OR PEPTIDE | DSM IP ASSETS BV (NL) | 2009-07-02 | — | — | WO | disclosed |
| EP-0822186-B1 | L-tert-leucine-2-pyridylamide | BRITISH BIOTECH PHARM (GB) | 2000-03-15 | — | — | EP | disclosed |
| CN-1049651-C | Metalloproteinase inhibitors | BRITISH BIOTECH PHARM (GB) | 2000-02-23 | — | — | CN | disclosed |
| EP-0740652-B1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARM (GB) | 1998-05-06 | — | — | EP | disclosed |
| EP-0822186-A2 | L-tert-leucine-2-pyridylamide | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1998-02-04 | — | — | EP | disclosed |
| CN-1138851-A | Metalloproteinase inhibitors | BRITISH BIOTECH PHARM (GB) | 1996-12-25 | — | — | CN | disclosed |
| EP-0740652-A1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1996-11-06 | — | — | EP | disclosed |
| WO-1995019956-A1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1995-07-27 | — | — | WO | disclosed |